Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

JAGX stock hub

Jaguar Health, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

JAGXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

JAGX

In the news

Latest news · JAGX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-80.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All JAGX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001585608
Company name	Jaguar Health, Inc.
Country	United States
Country code	US
Cusip	47010C862
Employees	47
Employees Change	-2%
Employees Change Percent	-4.08
Enterprise value	$43.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US47010C8626
Last refreshed	2026-05-10
Market cap	$1.2M
Market cap category	Nano-Cap
Price	$3
Price currency	USD
Rev Per Employee	244,914.89x
Sector	Healthcare
Sic	2834
Symbol	JAGX
Website	https://jaguar.health

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4,450.52%
EV Sales Forward	2.36x
EV/Sales	3.81x
FCF yield	-1,971.02%
P/S ratio	0.1x
PS Forward	0.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	67.21%
Gross Profit	$7.7M
Gross Profit Growth	-20.52%
Gross Profit Growth Q	-64.94%
Gross Profit Growth3 Y	-8%
Gross Profit Growth5 Y	4.45%
Net Income	$-53.6M
Net Income Growth Years	0%
Pretax Margin	-469.09%
Profit Per Employee	$-1.1M
ROA	-61.46
Roa5y	-47.03
ROCE	1,935.1
ROIC	-80.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-99.22%
Cagr3y	-95.53%
Cagr5y	-95.46%
EPS Growth Years	11
Revenue Growth	-1.52x
Revenue Growth Q	-7.81x
Revenue Growth Years	0x
Revenue Growth3 Y	-1.26x
Revenue Growth5 Y	4.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.25
Assets	$38.3M
Cash	$968,000
Current Assets	$20.3M
Current Liabilities	$40.7M
Debt	$43.6M
Equity	$-18.7M
Interest Coverage	-673.3
Liabilities	$57M
Long Term Assets	$18M
Long Term Liabilities	$16.4M
Net Cash	$-42.6M
Net Cash By Market Cap	$-3,542
Tangible Book Value	$-35.8M
Tangible Book Value Per Share	$-180
WACC	0.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.5
Inventory Turnover	0.4
Net Working Capital	$6.4M
Quick ratio	0.07
Working Capital	$-20.3M
Working Capital Turnover	$-2.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-99.22%
200-day SMA	43.63
3Y total return	-99.99%
50-day SMA	14.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	6,280,000,000
All Time High Change	-100%
All Time High Date	2017-08-04
All Time Low	2.53
All Time Low Change	18.58%
All Time Low Date	2026-05-06
ATR	1.47
Beta	0.03
Beta1y	2.02
Beta2y	2.79
Ch YTD	-90.8
High	3.28
High52	368.2
High52 Date	2025-05-08
High52ch	-99.19%
Low	2.8
Low52	2.53
Low52 Date	2026-05-06
Low52ch	18.58%
Ma50ch	-78.6%
Premarket Change Percent	-0.34
Premarket Price	$2.97
Premarket Volume	1,048
Price vs 200-day SMA	-93.12%
RSI	17.98
RSI Monthly	17.05
RSI Weekly	29.11
Sharpe ratio	-2.37x
Sortino ratio	-3.19
Tr YTD	-90.8
Tr1m	-79.07%
Tr1w	-55.16%
Tr3m	-87.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-2.04
Earnings Revenue Estimate	3,670,000x
Earnings Revenue Estimate Growth	65.76x
Operating Income	$-45.1M
Operating margin	-391.9
Price target	$2,100
Price Target Change	$69,900

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	374,707%
Float Percent	93.38%
Net Borrowing	12,693,000
Shares Insiders	6.62%
Shares Institutions	3.82%
Shares Out	401,264
Shares Qo Q	250.21%
Short Ratio	1.21

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-24.6M
Average Volume	86,408.45x
Bv Per Share	-99.2
CAPEX	$-41,000
Ch1m	-79.07
Ch1w	-55.16
Ch1y	-99.22
Ch3m	-87.21
Ch3y	-99.99
Ch5y	-100
Ch6m	-95.18
Change	0.67%
Change From Open	1.35
Close	2.98
Days Gap	-0.67
Depreciation Amortization	1,913,000
Dollar Volume	382,770
Earnings Date	2026-05-14
EBIT	$-45.1M
EBITDA	$-43.2M
EPS	$-804
F Score	3
FCF	$-23.7M
FCF EV Yield	-54.12x
FCF Per Share	$-59.13
Financing CF	23,670,000
Fiscal Year End	December
Founded	2,013
Investing CF	-41,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-07
Last Report Date	2025-12-31
Last Split Date	2026-04-30
Last Split Type	Reverse
Last10k Filing Date	2026-04-07
Ma150	34.64
Ma150ch	-91.34%
Ma20	9.82
Ma20ch	-69.44%
Net CF	-170,000
Next Earnings Date	2026-05-22
Open	2.96
Optionable	No
Position In Range	41.67
Ppne	1,463,000
Pre Close	2.98
Price Date	2026-05-08
Relative Volume	1.48x
Revenue	11,511,000x
SBC By Revenue	7.22x
Share Based Comp	831,000
Tr6m	-95.18%
Us State	California
Volume	127,590
Z Score	-18.77

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does JAGX pay a dividend?

Capital-return profile for this ticker.

Performance

JAGX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns JAGX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.8%

Float: +93.4% of shares outstanding

Insider ownership

+6.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

JAGX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

18.0

Below 30: short-term oversold

Price vs 200-day MA

-93.1%

50/200-day relationship not available

Beta (5Y)

0.03

Less volatile than the market

Sharpe ratio

-2.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About JAGX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current JAGX stock rating?

Jaguar Health, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full JAGX analysis?

The full report lives at /stocks/JAGX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for JAGX?

The latest report frames JAGX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the JAGX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.